Javascript must be enabled to continue!
Association Between Systemic Inflammatory Markers NLR and PLR in Patients with Type 2 Diabetes Mellitus
View through CrossRef
Type 2 diabetes is a metabolic inflammatory disease. However, Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) have emerged as potential inflammatory markers in patients with type 2 diabetes mellitus (T2DM). Therefore, its relationship with glycemic parameters remains controversial. This study aims to investigate the association between NLR, PLR, glycemic parameters, and hematological indices in patients with T2DM. A cross-sectional study was conducted on 65 patients with T2DM. Fasting blood sugar (FBS), glycated hemoglobin (HbA1c), and hematological indices were obtained from the medical record, including a complete blood count. NLR was calculated as the absolute neutrophil count divided by the absolute lymphocyte count, and PLR was calculated as the absolute platelet count divided by the absolute lymphocyte count. Data normality was assessed using the Shapiro-Wilk test. The data were non-normally distributed; Spearman's rank correlation was performed to investigate the associations between inflammatory markers and glycemic parameters. Statistical significance was set at p < 0.05. A total of 65 patients with T2DM were included (36 males, 55.4%; 29 females, 44.6%) with a mean age of 50±6.65 years. The mean level of FBS was 210±84 mg/dL, and the mean level of HbA1c was 9.34±2.16%. The study patient's cohort exhibited elevated systemic inflammatory markers. The mean NLR value was 3.0±2.89, and the mean PLR value was 153.08±130.89, both of which are higher than the standard reference ranges for healthy individuals. However, no statistically significant correlations were found between the inflammatory markers (NLR and PLR) and glycemic parameters. A strong and statistically significant positive correlation was observed between NLR and PLR (rho = 0.516, p < 0.001). NLR did not significantly correlate with FBS (rho = 0.025, p = 0.846) or HbA1c (rho = -0.044, p = 0.726). Similarly, no significant association was observed between PLR and FBS (rho = 0.100, p = 0.428) or HbA1c (rho = -0.048, p = 0.703).
Title: Association Between Systemic Inflammatory Markers NLR and PLR in Patients with Type 2 Diabetes Mellitus
Description:
Type 2 diabetes is a metabolic inflammatory disease.
However, Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) have emerged as potential inflammatory markers in patients with type 2 diabetes mellitus (T2DM).
Therefore, its relationship with glycemic parameters remains controversial.
This study aims to investigate the association between NLR, PLR, glycemic parameters, and hematological indices in patients with T2DM.
A cross-sectional study was conducted on 65 patients with T2DM.
Fasting blood sugar (FBS), glycated hemoglobin (HbA1c), and hematological indices were obtained from the medical record, including a complete blood count.
NLR was calculated as the absolute neutrophil count divided by the absolute lymphocyte count, and PLR was calculated as the absolute platelet count divided by the absolute lymphocyte count.
Data normality was assessed using the Shapiro-Wilk test.
The data were non-normally distributed; Spearman's rank correlation was performed to investigate the associations between inflammatory markers and glycemic parameters.
Statistical significance was set at p < 0.
05.
A total of 65 patients with T2DM were included (36 males, 55.
4%; 29 females, 44.
6%) with a mean age of 50±6.
65 years.
The mean level of FBS was 210±84 mg/dL, and the mean level of HbA1c was 9.
34±2.
16%.
The study patient's cohort exhibited elevated systemic inflammatory markers.
The mean NLR value was 3.
0±2.
89, and the mean PLR value was 153.
08±130.
89, both of which are higher than the standard reference ranges for healthy individuals.
However, no statistically significant correlations were found between the inflammatory markers (NLR and PLR) and glycemic parameters.
A strong and statistically significant positive correlation was observed between NLR and PLR (rho = 0.
516, p < 0.
001).
NLR did not significantly correlate with FBS (rho = 0.
025, p = 0.
846) or HbA1c (rho = -0.
044, p = 0.
726).
Similarly, no significant association was observed between PLR and FBS (rho = 0.
100, p = 0.
428) or HbA1c (rho = -0.
048, p = 0.
703).
Related Results
Systemic inflammation, TNM staging and survival in patients with lung cancer
Systemic inflammation, TNM staging and survival in patients with lung cancer
Abstract
Background
It is recognised that systemic inflammation plays an important role in the development and progressio...
Comparative Evaluation of Neutrophil-to-Lymphocyte ratio and Platelet-to-Lymphocyte ratio with Erythrocyte Sedimentation Rate and C-Reactive Protein as Markers of Systemic Inflammation.
Comparative Evaluation of Neutrophil-to-Lymphocyte ratio and Platelet-to-Lymphocyte ratio with Erythrocyte Sedimentation Rate and C-Reactive Protein as Markers of Systemic Inflammation.
Background: Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) are used as hematological markers of systemic inflammation. However, their performance compa...
Comparative Evaluation of Neutrophil-to-Lymphocyte ratio and Platelet-to-Lymphocyte ratio with Erythrocyte Sedimentation Rate and C-Reactive Protein as Markers of Systemic Inflammation.
Comparative Evaluation of Neutrophil-to-Lymphocyte ratio and Platelet-to-Lymphocyte ratio with Erythrocyte Sedimentation Rate and C-Reactive Protein as Markers of Systemic Inflammation.
Background: Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) are used as hematological markers of systemic inflammation. However, their performance compa...
Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Potential Predictors of Prognosis in Acute Ischemic Stroke
Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Potential Predictors of Prognosis in Acute Ischemic Stroke
Objective: Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have been emerging as the novel inflammatory biomarkers for determining the prognosis of vari...
Predictive Value of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios for Distant Metastasis in Vietnamese Gastric Cancer Patients
Predictive Value of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios for Distant Metastasis in Vietnamese Gastric Cancer Patients
Abstract
Background
Gastric cancer (GC) remains a leading cause of global cancer mortality, with a high prevalence of distant m...
Prognostic value of lymphocyte cell ratios in peritoneal dialysis
Prognostic value of lymphocyte cell ratios in peritoneal dialysis
Background: Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have been introduced as useful inflammatory markers to predict the outcome of a wide spectru...
Impact of Neoadjuvant Chemotherapy on Hormone Receptor Status and Systemic Inflammatory Markers in Breast Cancer Patients: A Retrospective Cohort Study
Impact of Neoadjuvant Chemotherapy on Hormone Receptor Status and Systemic Inflammatory Markers in Breast Cancer Patients: A Retrospective Cohort Study
Introduction: Breast Cancer (BC) remains the leading cause of cancer-related morbidity and mortality among women worldwide. Neoadjuvant Chemotherapy (NACT) is important in treating...
Neutrophil- Lymphocyte Ratio (NLR) and Platelet- Lymphocyte Ratio (PLR) as Inflammatory Markers in Preterm Birth
Neutrophil- Lymphocyte Ratio (NLR) and Platelet- Lymphocyte Ratio (PLR) as Inflammatory Markers in Preterm Birth
Introduction: Preterm births make up roughly 16–18% of all live births in Indonesia. One of the factors that contribute to preterm birth is inflammation. The study aimed to assess ...

